Sanofi acquires Dynavax for $2.2B, boosting its vaccine portfolio with HEPLISAV-B and a shingles candidate. Click for my ...

A new form of the flu, which is highly contagious and aggressive, is sweeping the nation this season. A mutation of influenza ...

Get the latest Moderna (MRNA) stock analysis: balanced risk-reward, new vaccine launches, and pipeline insights. See why we ...

A six-year-old girl from Maharashtra died after a dog bite despite receiving an anti-rabies vaccination. Doctors say such ...

The country has reduced the number of children who had never been vaccinated by half, according to The Lancet.

Public health experts say Europeans can afford to vaccinate less because they have universal access to health care.

The elderly population has more than doubled between 1980 and 2020. How do the elderly know vaccines work? Because they’ve ...

Although Abhayrab is not approved or supplied in Australia, individuals who received this vaccine while visiting India may ...

In 2025, infectious diseases resurged globally due to climate change, conflict, and declining vaccination coverage. Bird flu, ...

SANOFI said on Wednesday it will buy US biotech Dynavax Technologies for around $2.2 billion (1.9 billion euros) in an agreed deal that will add an adult hepatitis B vaccine and a promising ...

Kennedy, a long-time anti-vaccine activist, has made no secret of his eagerness to revamp the immunization schedule. After ...

Here are the top 5 most-read vaccine articles in 2025.